News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|April 20, 2016

Monitoring Patients

Episodes in this series

EP. 1 Types of Multiple Myeloma

EP. 1 Types of Multiple Myeloma

EP. 2 Testing Procedures and Considerations

EP. 2 Testing Procedures and Considerations

EP. 3 Considerations For Treatment

EP. 3 Considerations For Treatment

EP. 4 Monitoring Patients

EP. 4 Monitoring Patients

EP. 5 Top Considerations for Maintenance Therapy

EP. 5 Top Considerations for Maintenance Therapy

EP. 6 New Drug Classes For Treatment

EP. 6 New Drug Classes For Treatment

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 8 Professional Expectations for Future

EP. 8 Professional Expectations for Future

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Laura.

How Cancer Stole My Peace of Mind and Taught Me Resilience

February 11th 2026

Mary Royal and Dr. Pablo Prichard

MRD Testing May Offer Peace of Mind to Breast Cancer Survivors

ByMary Royal,Dr. Pablo Prichard

February 11th 2026

"FDA"

FDA Clears PD-L1 Test to Guide Keytruda Use in Ovarian Cancer

February 11th 2026

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use with JAK inhibitors: © stock.adobe.com.

FDA Clears Protocol Update for Tasquinimod in Myelofibrosis Trial

February 11th 2026

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

A Family’s Strength Through Liver Cancer and Living Donation

February 11th 2026

Trending on CURE

Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer

Why Subcutaneous Darzalex Faspro Matters for Patients With Multiple Myeloma

FDA Grants Designation to Immunotherapy KB707 for Advanced NSCLC

FDA Fast Track Designation Highlights New Option in Advanced Liver Cancer

FDA Clears Phase 2b Study of Teverelix in Advanced Prostate Cancer